Skip to main content
. Author manuscript; available in PMC: 2022 Apr 18.
Published in final edited form as: IEEE Trans Biomed Eng. 2022 Mar 18;69(4):1449–1460. doi: 10.1109/TBME.2021.3119280

Fig. 1.

Fig. 1.

Study design diagram. A) At EDD-09 a total of 52 CAMs were engrafted with the HCT-116 cell line and 47 CAMs were engrafted with the HT-29 cell line. B) The tumor engrafted CAMs were randomized, and a pretreatment ULM imaging session was performed on EDD-13. C) The tumors underwent their selected therapy as described in the methods section, and a post-treatment ULM imaging session was performed on EDD-17. Tumors were excised immediately after imaging and formalin fixed for histology.